ABSTRACT
BACKGROUND: Shift rotation schemes can influence workers' tolerance of night-shift work and its impact on health. AIMS: This study was aimed to assess the influence of shift work rotation schemes on sleepiness and sleep quality. METHODS: We conducted a cross-sectional study of 145 male workers, 77 from a ceramic tile factory on a fixed, forward-rotating shift work scheme, and 68 from a dockyard company, working on-call night shifts. Participants self-administered the Epworth Sleepiness Scale (ESS) and the Pittsburgh Sleep Quality Index (PSQI) questionnaires and provided data on demographic and lifestyle variables. We set two logistic regression models to predict the risk of daytime sleepiness and poor sleep quality as a function of night-shift work and on-call night shifts, adjusting for personal and lifestyle covariates. RESULTS: Marital status, body mass index, smoking and alcohol intake did not affect ESS and PSQI scores, nor did they differ between the two cohorts. Night-shift workers from both cohorts were more likely to have a PSQI score ≥6, suggestive of poor sleep quality, with no variation between the two cohorts. ESS scores suggestive of daytime sleepiness were strongly associated with on-call night shifts among dockyard workers for (odds ratio = 13.4; 95% confidence interval 2.9-63.9), in respect the regular, forward-rotating night-shift work among ceramic tile factory workers. DISCUSSION: Daytime sleepiness occurred more frequently among dockyard workers working on-call night shifts. Poor sleep quality occurred more frequently among night-shift workers, but it did not differ between the two companies.
Subject(s)
Sleep Quality , Sleepiness , Cross-Sectional Studies , Humans , Male , Sleep , Surveys and Questionnaires , Work Schedule ToleranceABSTRACT
BACKGROUND: The current study aimed to evaluate the influence of regular annual influenza vaccinations on cardiovascular (CV) death and heart failure-related hospitalizations (HFrH) in stable outpatients with heart failure with reduced ejection fraction. METHODS: The Turkish research team-HF (TREAT-HF) is a network undertaking multicenter, observational cohort studies in HF. This study is a subgroup analysis of TREAT-HF outpatient cohorts who completed a questionnaire on influenza vaccination status and for whom follow-up data were available. A total of 656 patients with available follow-up data for CV death and HFrH including recurrent hospitalization were included in the study. Patients were classified into two groups: those who received regular influenza vaccination (40 %) and those who did not receive vaccination. RESULTS: During a mean follow-up of 15 ±6 months, 113 (18 %) patients had CV death and 471 (72 %) patients had at least one HFrH. The CV death rate was similar in both groups of patients (16 vs. 19 %, p = 0.37), whereas, HFrH and recurrent HFrH were significantly less frequently encountered in patients who received regular influenza vaccination than in those who did not receive vaccination (43 vs. 92 % and 16 vs. 66 %, p < 0.001, respectively). In a multivariate Cox proportional hazards model - in addition to a few clinical factors - vaccination status (HR = 0.30, 95 % CI = 0.17-0.51, p < 0.001) and graduation from university (HR = 0.35, 95 % CI = 0.17-0.72, p = 0.004) remained independently associated with the risk of recurrent HFrH. CONCLUSION: Regular influenza vaccination does not influence CV deaths; however, it decreases HFrH including recurrent episodes of HFrH in outpatients with heart failure with reduced ejection fraction.
Subject(s)
Death, Sudden, Cardiac/epidemiology , Heart Failure/mortality , Influenza Vaccines/therapeutic use , Influenza, Human/mortality , Influenza, Human/prevention & control , Patient Readmission/statistics & numerical data , Vaccination/statistics & numerical data , Comorbidity , Death, Sudden, Cardiac/prevention & control , Female , Follow-Up Studies , Heart Failure/prevention & control , Humans , Male , Middle Aged , Prevalence , Risk Factors , Turkey/epidemiologyABSTRACT
Members of the phylum Myxozoa are among the most cosmopolitan parasites of fish, and the genus Myxobolus is the largest within the class Myxosporea in freshwater and marine environment from all over the world. Myxobolus parvus has been reported from mainly mugilid fishes from different localities including the Black Sea. Leaping mullet Liza saliens collected by fishermen off Sinop coasts of the Black Sea in the period between September 2014 and December 2015 was investigated for myxosporean parasites using conventional methods. M. parvus Schulman, 1962 was the only Myxobolus species identified and it was found in the gills, gall bladder, kidney tubules, and inside several cysts located on the lower jaw of examined fish in the present study. Morphometric data and all details of parasitic infection were determined and presented in tables and illustrated in figures. Molecular characterization was also conducted to reveal its position within Myxosporea. Two M. parvus samples from gills and kidney showed the same haplotype and appeared in the same sub-lineage with marine Myxobolus species. The closest haplotypes to M. parvus were Triactinomyxon sp. and Endocapsa sp. which are the actinosporeans forms of unknown myxozoan species. These data are the first in molecular characterization of M. parvus, its occurrence in lower jaw of leaping mullet along with its infection prevalence values off the Turkish Black Sea coasts.
Subject(s)
Fish Diseases/parasitology , Myxobolus/classification , Myxobolus/isolation & purification , Parasitic Diseases, Animal/parasitology , Smegmamorpha/parasitology , Animals , Black Sea , Fresh Water/parasitology , Gills/parasitology , Phylogeny , TurkeyABSTRACT
OBJECTIVES: Asymmetric tonsillar hypertrophy is a condition, confirmed by physical examination, that can be found in every age group. The aim of this study was to compare each tonsil through macroscopic and microscopic assessment of specimens and reveal the reasons that cause one tonsil to grow more than the other. METHODOLOGY: The study was carried out with 93 patients who wereindicated for tonsillectomy in the authors' Clinic. Of these 93 patients, seven cases who had clinically asymmetric but pathologically symmetric tonsils were excluded from the study. The presence of microscopicintraepithelial abscess, Helicobacter pylori with Giemsa stain, Coccobacillus, fungus, Actinomyces with Pas-Grocott stain, dysplasia or hyperplasia, malignancy and reactive changes in the epithelium were evaluated. RESULTS: The study was conducted with 86 patients aged between two and 35, of whom 32 were women (37.2%) and 54 were men (62.8%). The mean age of cases was 8.37 ± 5.95. The mean difference between two tonsils ranged from 1 to 12 mm, mean 3.67 ± 2.56 mm. When the findings were examined, the presence of H. pylori, Coccobacillus, fungus and Actinomyces, reactive changes in the epithelium, pattern of hyperplasia, intraepithelial abscess and macroscopic presence of pus did not reveal any statistically significant changes. CONCLUSION: The reasons behind asymmetric tonsil hypertrophies and how they are related to malignancies have not yet been clarified. There is no statistically significant difference between the evaluated parameters in the present study. This study has brought a new point of view to the subject by comparing different-sized tonsils in the same person, thus paving the way for future studies with a broader scope.
Subject(s)
Palatine Tonsil/pathology , Abscess/pathology , Actinomyces/isolation & purification , Adolescent , Adult , Child , Child, Preschool , Epithelium/pathology , Female , Gram-Negative Aerobic Rods and Cocci/isolation & purification , Helicobacter pylori/isolation & purification , Humans , Hypertrophy/etiology , Male , Palatine Tonsil/surgery , Suppuration/pathology , Tonsillectomy , Young AdultSubject(s)
Cysts/diagnostic imaging , Cysts/surgery , Heart Neoplasms/diagnostic imaging , Heart Neoplasms/surgery , Myxoma/diagnostic imaging , Myxoma/surgery , Diagnosis, Differential , Echocardiography, Three-Dimensional/methods , Heart Atria/diagnostic imaging , Heart Atria/surgery , Humans , Male , Middle Aged , Treatment OutcomeSubject(s)
Coronary Vasospasm/complications , Coronary Vasospasm/diagnosis , Myocardial Infarction/diagnosis , Myocardial Infarction/etiology , Nitroglycerin/administration & dosage , Coronary Angiography/methods , Coronary Vessels/drug effects , Diagnosis, Differential , Dose-Response Relationship, Drug , Electrocardiography/methods , Humans , Male , Middle Aged , Vasodilator Agents/administration & dosageSubject(s)
Myocardial Infarction/chemically induced , Myocardial Infarction/diagnosis , Pseudoephedrine/adverse effects , Adolescent , Common Cold/complications , Common Cold/drug therapy , Humans , Male , Myocardial Infarction/prevention & control , Nasal Decongestants/adverse effects , Nasal Decongestants/therapeutic use , Pseudoephedrine/therapeutic use , Treatment OutcomeABSTRACT
Chronic upper limb ischemia is an uncommon clinical condition and is most often caused by subclavian artery stenosis. Surgical and percutaneous treatment modalities have been shown to be effective for the management of subclavian artery occlusion. Because of lower mortality and morbidity rates, percutaneous interventions for subclavian arterial occlusions are more acceptable than surgery. Chronic total occlusions of the subclavian artery are challenging to treat percutaneously because of the structure and complexity of the lesion. The complexity of the lesion causes its own complications. In this paper, we report a case of a completely occluded left subclavian artery that was complicated by a malpositioned stent hanging into the aortic arch and the ascending aorta during percutaneous intervention, which was successfully managed by our heart team.
Subject(s)
Arm/blood supply , Device Removal/methods , Ischemia/etiology , Stents , Subclavian Steal Syndrome/complications , Subclavian Steal Syndrome/surgery , Aorta , Combined Modality Therapy/methods , Humans , Ischemia/diagnosis , Ischemia/prevention & control , Male , Middle Aged , Subclavian Steal Syndrome/diagnosis , Treatment OutcomeSubject(s)
Blood Vessel Prosthesis/adverse effects , Coronary Vessels/injuries , Coronary Vessels/surgery , Stents/adverse effects , Wounds, Penetrating/etiology , Wounds, Penetrating/surgery , Adult , Device Removal , Humans , Male , Prosthesis Failure/adverse effects , Radiography , Treatment Outcome , Wounds, Penetrating/diagnostic imagingSubject(s)
Bacteremia/diagnosis , Brucellosis/diagnosis , Coronary Artery Disease/diagnosis , Embolism/diagnosis , Endocarditis, Bacterial/diagnosis , Myocardial Infarction/diagnosis , Bacteremia/etiology , Bacteremia/therapy , Brucellosis/complications , Brucellosis/therapy , Coronary Artery Disease/etiology , Coronary Artery Disease/therapy , Embolism/etiology , Embolism/therapy , Endocarditis, Bacterial/complications , Endocarditis, Bacterial/therapy , Humans , Male , Middle Aged , Myocardial Infarction/etiology , Myocardial Infarction/therapyABSTRACT
OBJECTIVE: Total atrial conduction time (TACT) is the most important parameter in predicting the development of new-onset atrial fibrillation. We investigated the effect of cilostazol therapy on TACT in patients with peripheral artery disease. METHODS: Thirty patients with peripheral artery disease were treated with cilostazol (200 mg/day) for 6 months. The baseline echocardiographic total atrial conduction time parameter was compared with the 6-month follow-up. RESULTS: The TACT duration was decreased in all patients compared with the baseline after therapy (121.8 ± 19.3 vs. 109.1 ± 15.9 milliseconds, p<0.001). However, left atrial (LA) diameter was not changed with the therapy. The reduction of TACT duration was correlated with the increase in mitral E wave velocity/mitral A wave velocity ratio (r=-0.48, p<0.003). CONCLUSION: Our results showed that 200 mg cilostazol treatment decreased TACT duration in patients with peripheral artery disease, which may also prevent the development and/or recurrence of atrial fibrillation (AF).
Subject(s)
Peripheral Arterial Disease/drug therapy , Peripheral Arterial Disease/physiopathology , Tetrazoles/administration & dosage , Vasodilator Agents/administration & dosage , Aged , Atrial Fibrillation/etiology , Atrial Fibrillation/physiopathology , Atrial Fibrillation/prevention & control , Cilostazol , Female , Follow-Up Studies , Humans , Male , Middle Aged , Peripheral Arterial Disease/complicationsSubject(s)
Echocardiography, Transesophageal/methods , Mitral Valve Insufficiency/etiology , Mitral Valve Insufficiency/surgery , Punctures , Surgical Instruments , Thrombosis/complications , Thrombosis/diagnostic imaging , Aged , Diagnosis, Differential , Humans , Male , Mitral Valve Insufficiency/diagnostic imaging , Treatment FailureSubject(s)
Atrial Fibrillation/complications , Atrial Fibrillation/diagnostic imaging , Heart Septum/diagnostic imaging , Heart Ventricles/diagnostic imaging , Thrombosis/diagnostic imaging , Thrombosis/etiology , Aged, 80 and over , Atrial Fibrillation/surgery , Diagnosis, Differential , Female , Heart Septum/surgery , Heart Ventricles/surgery , Humans , Thrombosis/surgery , Treatment Outcome , UltrasonographyABSTRACT
BACKGROUND: Non-invasive prediction of paroxysmal atrial fibrillation (PAF) is one of the most recent interests of cardiology. AIM: The current study investigates the relationship between the atrial electromechanical coupling time (EMCT) and PAF. PATIENTS AND METHODS: A group of 35 patients with PAF was compared with a group of 37 subjects without PAF. Pulsed wave tissue Doppler evaluations of atrial walls were performed from apical four chambers view under ECG monitoring. The time intervals from the onset of P wave to the onset of late diastolic wave (A') at right atrial wall (P-RA), interatrial septum (P-IAS), and left atrial wall (P-LA, maximum EMCT) were measured. The right atrial EMCT (P-RA minus P-IAS), left atrial EMCT (P-LA minus P-IAS) and interatrial EMCT (P-LA minus P-RA) were computed. A' wave velocities were measured from each atrial wall. RESULTS: RA (16.0±13.1 vs. -8.7±18.6 ms, p < 0.001) and maximum (91.5±32.6 vs. 72.0±23.1 ms, p = 0.001) EMCT were longer, RA A' velocity was higher in the patient group. There were no differences between the groups in LA and interatrial EMCT, and septal and LA A' velocities. Regression analysis revealed that only RA [OR: 1.148 (1.041-1.267), p = 0.006] and maximum [OR: 1.099 (1.009-1.197), p = 0.031] EMCT were independent variables for PAF. In order to predict patients with PAF, we have chosen +7.5 msn for the RA EMCT which yielded 69% sensitivity and 71.4% specificity to predict patients. CONCLUSIONS: Delayed RA lateral EMCT relative to septal one and delayed maximum EMCT detected by tissue Doppler could be a valuable method for identifying patients with PAF.
Subject(s)
Atrial Fibrillation/physiopathology , Atrial Septum/physiopathology , Echocardiography, Doppler, Pulsed , Heart Atria/physiopathology , Adult , Aged , Case-Control Studies , Electrocardiography, Ambulatory , Female , Humans , Male , Middle Aged , Prospective Studies , Regression Analysis , Sensitivity and Specificity , Time FactorsABSTRACT
BACKGROUND: No data exist on regarding possible improvement will occur in right ventricular (RV) functions after successful recanalization of right coronary artery chronic total occlusions (RCA CTOs). AIM: Our aim was to evaluate the revascularization induced changes in RV functions by novel echocardiographic techniques like tissue Doppler imaging (TDI) and two dimensional speckle tracking echocardiography (2DSTE). PATIENTS AND METHODS: Forty-one consecutive successfully recanalized patients with RCA CTOs were included in our study. All included patients underwent standard echocardiography with TDI and 2DSTE to assess RV function before procedure and repeated after 24 hours and 1 month. RESULTS: There were no significant changes in tricuspid annular plane systolic excursion, systolic myocardial velocities, and fractional area change values. However, RV global longitudinal strain and systolic strain rate values showed a significant increase at 24 hours after percutaneous coronary intervention compared to baseline (-23.6±4.1% vs. -19.7±3.9%, p < 0.001 and -1.55±0.18s-1 vs. -1.18±0.17s-1, p < 0.001, respectively). Moreover, improvement of the RV functions in patients with RCA CTOs was further suggested by the higher RV isovolumic acceleration values at 1-month compared with baseline (2.29±0.62 vs. 2.05±0.5 m/s2, p = 0.014). CONCLUSIONS: TDI derived isovolumic acceleration and 2DSTE derived global longitudinal strain and systolic strain rate values showed improvement in RV functions after successful percutaneous recanalization of RCACTOs suggesting viability of RV in chronic ischemia.
Subject(s)
Coronary Occlusion/surgery , Echocardiography , Percutaneous Coronary Intervention , Ventricular Function, Right , Aged , Chronic Disease , Coronary Occlusion/diagnostic imaging , Coronary Occlusion/physiopathology , Female , Humans , Male , Middle Aged , SystoleABSTRACT
AIM: To assess early outcome of predilatation prior stenting of severe carotid artery stenosis and to evaluate early major adverse cardiovascular and cerebral events (MACCE). PATIENTS AND METHODS: The study group consisted of 265 consecutive patients (200 males, 65 female, mean age 66.7 ± 8.6 years) in whom 275 percutaneous transluminal angioplasty (PTA) procedures of carotid arteries were performed. Staged carotid stenting was performed in patients with bilateral carotid stenosis. Neuroprotection with a distal protection device was used in all cases. The patients were divided into two groups: direct carotid stent implantation without previous pre-dilation was performed in 233 patients (direct stenting group) and predilatation was performed in 42 patients (predilatation group). Early events were recorded and analyzed subsequently. RESULTS: We treated 275 carotid stenoses and the stent was implanted in all patients. Ten patients (3.7%) were treated by staged carotid artery stenting (CAS) due to bilateral carotid artery disease. The technical success rate was 97.1%. During 1-month follow-up, the prevalence of primary endpoint was 2.18%. The prevalence of MACCE at 30 days was higher in the predilatation group (2.4% vs. 2.1%; p = 0.924). Also periprocedural rate of hypotension was higher in predilatation group (7.1% vs. 1.7%; p = 0.04). CONCLUSIONS: Balloon predilatation prior to stenting can be performed to treat severe carotid artery stenosis with acceptable periprocedural complication rate.
Subject(s)
Angioplasty, Balloon, Coronary/adverse effects , Angioplasty, Balloon, Coronary/methods , Carotid Stenosis/surgery , Dilatation/adverse effects , Dilatation/methods , Aged , Female , Humans , MaleABSTRACT
BACKGROUND: Recent findings suggest that there is a close relationship between chronic heart failure and uric acid. AIMS: The aim of the study was to assess whether increased uric acid levels in patients with dilated cardiomyopathy might correlate with the degree of functional mitral regurgitation (MR). MATERIALS AND METHODS: Sixty two consecutive patients diagnosed with dilated cardiomyopathy were included in the study. The patients were classified according to severity of functional MR into two groups: mild-moderate functional MR (ERO < 0.2 cm2) and severe functional MR. RESULTS: The patients with severe functional MR had significantly higher serum uric acid levels compared to patients without severe functional MR (6.34 ± 1.61 mg/dL vs 5.43 ± 1.17 mg/dL respectively, p = 0.012). Furthermore, tenting area, an important predictor of functional MR severity, was moderately correlated with the serum uric acid levels (r = 0.351, p = 0.005). It was also shown that the serum uric acid concentrations were inversely correlated with left ventricular (LV) ejection fraction, and positively correlated with LV volumes. There was also a significant relation between the serum uric acid and left atrial volumes and also brain natriuretic peptide (BNP) levels. CONCLUSIONS: In conclusion, this study demonstrates that elevated serum uric acid levels in patients with dilated cardiomyopathy are correlated with the severity of functional MR and echocardiographic volume indices.
Subject(s)
Cardiomyopathy, Dilated/blood , Mitral Valve Insufficiency/blood , Uric Acid/metabolism , Adult , Biomarkers/blood , Cardiomyopathy, Dilated/complications , Echocardiography/methods , Echocardiography/statistics & numerical data , Female , Humans , Male , Middle Aged , Mitral Valve Insufficiency/complications , Natriuretic Peptide, Brain/metabolism , Severity of Illness IndexABSTRACT
Atrial septal defect is a common form of congenital heart disease. Percutenous closure is an important treatment option for these patients. In this case series, we intend to share the percutaneous closure of the difficult types of secundum atrial septal defects.
Subject(s)
Cardiac Catheterization/instrumentation , Echocardiography, Transesophageal/methods , Heart Septal Defects, Atrial/therapy , Adult , Female , Heart Septal Defects, Atrial/diagnostic imaging , Humans , Male , Treatment OutcomeABSTRACT
Keutel syndrome (KS) is a rare autosomal recessive disease which is mainly characterised by abnormal cartilage calcification, peripheral pulmonary artery stenosis, sensorineural and conductive hearing loss, brachytelephalangism, and midface hypoplasia. Here, we present and discuss a Keutel syndrome patient with hearing loss born to consanguineous parents (first cousins), along with all the characteristic features of KS.